This trial will help establish a novel treatment strategy for patients with peripheral clinical stage IA3 pure-solid NSCLC.
No takes yet. Share an insight, caveat, or question.
Kamigaichi et al. (2024) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: